About
Technology
Issues
FAQ
Links
Official Page
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.